0
Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023
12/19/2023, 9:00 PM
Summary of Bill S 2303
The bill is named after Stephanie Tubbs Jones, a former member of Congress who was a strong advocate for women's health issues. The main goal of the bill is to increase funding for research into uterine fibroids and to improve education and awareness about the condition.
If passed, the bill would allocate additional resources to the National Institutes of Health (NIH) for research on uterine fibroids. This research would aim to better understand the causes of uterine fibroids, improve diagnosis and treatment options, and ultimately find a cure for the condition. In addition to funding research, the bill also includes provisions to improve education and awareness about uterine fibroids. This would involve developing educational materials for healthcare providers and patients, as well as conducting outreach programs to raise awareness about the condition. Overall, the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023 seeks to address the significant impact that uterine fibroids have on women's health and quality of life. By increasing research funding and improving education and awareness, the bill aims to advance the understanding and treatment of this common yet often overlooked condition.
Congressional Summary of S 2303
Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2023
This bill directs the Department of Health and Human Services (HHS) to expand research on, and take other actions to address, uterine fibroids. These are muscular tumors that grow in the wall of the uterus and may cause pain, heavy menstrual bleeding, and reproductive issues.
In coordination with the National Institutes of Health and appropriate federal agencies, HHS must undertake research activities on uterine fibroids.
In addition, HHS must establish a database of services furnished to individuals diagnosed with uterine fibroids under Medicaid or the Children's Health Insurance Program and must develop a report on federal and state expenditures for such services.
Additionally, HHS must disseminate information on uterine fibroids to the public and to health care providers, including information on the elevated risk for minority women and available treatments.

